Lilly taps obesity windfall for more M&A. Plus, Elon Musk remarks pull GE Vernova lower

Eli Lilly announced plans to use revenue gains from its obesity drugs to fund additional mergers and acquisitions. The company's weight-loss medications have generated significant sales growth. Separately, shares of GE Vernova declined following remarks by Elon Musk. Musk's specific comments and their connection to GE Vernova were not detailed in the available text.

Next story